Development and Assessment of Live Microbiome-Based Products: Fecal Microbiota for Transplantation (FMT) and Live Biotherapeutic Products (LBPs) - COVID-19
$77,000Y01FY2020AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Abstract
This project will assess SARS-CoV-2 stool shedding and the risks of transmission.
View original record on NIH RePORTER →